O
OrbiMed’s Johnson & Johnson JNJ Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-414,100
| Closed | -$57.2M | – | 135 |
|
2018
Q3 | $57.2M | Sell |
414,100
-341,900
| -45% | -$47.2M | 0.69% | 42 |
|
2018
Q2 | $91.7M | Buy |
756,000
+290,700
| +62% | +$35.3M | 1.09% | 32 |
|
2018
Q1 | $59.6M | Hold |
465,300
| – | – | 0.74% | 45 |
|
2017
Q4 | $65M | Sell |
465,300
-659,100
| -59% | -$92.1M | 0.82% | 40 |
|
2017
Q3 | $146M | Hold |
1,124,400
| – | – | 1.4% | 24 |
|
2017
Q2 | $149M | Buy |
1,124,400
+239,800
| +27% | +$31.7M | 1.56% | 20 |
|
2017
Q1 | $110M | Buy |
884,600
+26,600
| +3% | +$3.31M | 1.25% | 28 |
|
2016
Q4 | $98.9M | Hold |
858,000
| – | – | 1.26% | 28 |
|
2016
Q3 | $101M | Buy |
858,000
+80,400
| +10% | +$9.5M | 1.15% | 30 |
|
2016
Q2 | $94.3M | Buy |
777,600
+245,800
| +46% | +$29.8M | 0.98% | 35 |
|
2016
Q1 | $57.5M | Buy |
531,800
+239,800
| +82% | +$25.9M | 0.61% | 44 |
|
2015
Q4 | $30M | Hold |
292,000
| – | – | 0.27% | 64 |
|
2015
Q3 | $27.3M | Sell |
292,000
-325,000
| -53% | -$30.3M | 0.28% | 64 |
|
2015
Q2 | $60.1M | Buy |
617,000
+4,000
| +0.7% | +$390K | 0.5% | 50 |
|
2015
Q1 | $61.7M | Buy |
613,000
+118,000
| +24% | +$11.9M | 0.53% | 51 |
|
2014
Q4 | $51.8M | Buy |
495,000
+72,000
| +17% | +$7.53M | 0.49% | 47 |
|
2014
Q3 | $45.1M | Sell |
423,000
-59,000
| -12% | -$6.29M | 0.47% | 47 |
|
2014
Q2 | $50.4M | Sell |
482,000
-115,000
| -19% | -$12M | 0.59% | 43 |
|
2014
Q1 | $58.6M | Sell |
597,000
-29,000
| -5% | -$2.85M | 0.72% | 40 |
|
2013
Q4 | $57.3M | Sell |
626,000
-27,000
| -4% | -$2.47M | 0.84% | 38 |
|
2013
Q3 | $56.6M | Buy |
653,000
+452,000
| +225% | +$39.2M | 1.01% | 30 |
|
2013
Q2 | $17.3M | Buy |
+201,000
| New | +$17.3M | 0.37% | 50 |
|